SCHEMBL26077351

SCHEMBL26077351

COC(=O)c1cc(Oc2ccc(N3CCCCC3)nc2)nc(-c2cc(Cl)cc(Cl)c2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FURIN P09958 6/20 0.44
▸ RAB9A P51151 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CSF1R P07333 1/20 0.39
▸ DAPK1 P53355 1/20 0.39
▸ ESR1 P03372 1/20 0.38
▸ CNR2 P34972 2/20 0.38
▸ CACNA1H O95180 1/20 0.37
▸ GPR119 Q8TDV5 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NR2C2 P49116 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ TAB1 Q15750 1/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26077350 0.86 ALDH1A1 (0.45) FURINRAB9ANPC1KMT2ACSF1R
SCHEMBL21550824 0.86 GPR119 (0.45) FURINGPR119
SCHEMBL26077221 0.85 FURIN (0.51) FURINRAB9ANPC1KMT2ACSF1R
SCHEMBL26077248 0.82 RAB9A (0.43) FURINRAB9ANPC1KMT2ACSF1R
SCHEMBL26077352 0.81 FURIN (0.42) FURINESR1CNR2FFAR4
SCHEMBL26077220 0.81 GPR119 (0.51) FURINRAB9ANPC1KMT2ACSF1R
SCHEMBL26077353 0.78 FURIN (0.41) FURINESR1CNR2FFAR4
SCHEMBL26077354 0.76 FURIN (0.65) FURIN
SCHEMBL21551228 0.76 FURIN (0.52) FURINRAB9ANPC1KMT2AGPR119
SCHEMBL21551173 0.73 FURIN (0.44) FURINKMT2AALDH1A1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773078-B2 Furin inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773078-B2 Furin inhibitors FURIN, TGFB1, PCSK7 FURIN 1/4885RAB9A 352/4885NPC1 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback